---
title: Health-related quality of life of children with X-linked hypophosphatemia in
  Germany
date: '2024-06-24'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38914781/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240625182106&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: In this real-world study in pediatric XLH patients, HRQoL
  was average or even slightly above that of the general population, likely due to
  the fact that the vast majority of patients had their treatment modality switched
  from conventional treatment to burosumab resulting in improved physical health and
  ...'
disable_comments: true
---
CONCLUSIONS: In this real-world study in pediatric XLH patients, HRQoL was average or even slightly above that of the general population, likely due to the fact that the vast majority of patients had their treatment modality switched from conventional treatment to burosumab resulting in improved physical health and ...